EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass Spectrometry

Michael Woolman, Taira Kiyota, Siham A Belgadi, Naohide Fujita, Alexa Fiorante, Vijay Ramaswamy, Craig Daniels, James T Rutka, Chris McIntosh iD, David G Munoz, Howard J Ginsberg, Ahmed Aman iD und 1 weitere

Analytical Chemistry · 23.01.2024 · 96 (3) · 1019-1028

DOI: 10.1021/acs.analchem.3c03156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 08.01.2024. Verfasst von Michael Woolman und 12 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, Ontario M5G 1L7, Canada. Hauptthemen laut MEDLINE: Brain Neoplasms, Cerebellar Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Government of Canada, Princess Margaret Cancer Foundation, Canadian Cancer Society Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Picosecond infrared laser mass spectrometry (PIRL-MS) is shown, through a retrospective patient tissue study, to differentiate medulloblastoma cancers from pilocytic astrocytoma and two molecular subtypes of ependymoma (PF-EPN-A, ST-EPN-RELA) using laser-extracted lipids profiled with PIRL-MS in 10 s of sampling and analysis time. The average sensitivity and specificity values for this classification, taking genomic profiling data as standard, were 96.41 and 99.54%, and this classification used many molecular features resolvable in 10 s PIRL-MS spectra. Data analysis and liquid chromatography coupled with tandem high-resolution mass spectrometry (LC-MS/MS) further allowed us to reduce the molecular feature list to only 18 metabolic lipid markers most strongly involved in this classification. The identified 'metabolite array' was comprised of a variety of phosphatidic and fatty acids, ceramides, and phosphatidylcholine/ethanolamine and could mediate the above-mentioned classification with average sensitivity and specificity values of 94.39 and 98.78%, respectively, at a 95% confidence in prediction probability threshold. Therefore, a rapid and accurate pathology classification of select pediatric brain cancer types from 10 s PIRL-MS analysis using known metabolic biomarkers can now be available to the neurosurgeon. Based on retrospective mining of 'survival' versus 'extent-of-resection' data, we further identified pediatric cancer types that may benefit from actionable 10 s PIRL-MS pathology feedback. In such cases, aggressiveness of the surgical resection can be optimized in a manner that is expected to benefit the patient's overall or progression-free survival. PIRL-MS is a promising tool to drive such personalized decision-making in the operating theater.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCerebellar NeoplasmsHumansChildChromatography, LiquidLipidomicsRetrospective StudiesInfrared RaysTandem Mass SpectrometryLasers

Autor:innen und Institutionen

  • Princess Margaret Cancer Centre, University Health Network, 101 College Street, Toronto, Ontario M5G 1L7, Canada.
  • Department of Medical Biophysics, University of Toronto, 101 College Street, Toronto, Ontario M5G 1L7, Canada.
  • Ontario Institute for Cancer Research (OICR), 661 University Ave Suite 510, Toronto, Ontario M5G 0A3, Canada.
  • Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, 686 Bay Street, Toronto, Ontario M5G 0A4, Canada.
  • Department of Surgery, University of Toronto, 149 College Street, Toronto, Ontario M5T 1P5, Canada.
  • Toronto General Hospital Research Institute, University Health Network, 200 Elizabeth Street, Toronto, Ontario M5G-2C4, Canada.

ORCID-Profile: Chris McIntosh, Ahmed Aman, Arash Zarrine-Afsar

Förderung

  • Government of Canada
  • Princess Margaret Cancer Foundation
  • Canadian Cancer Society Research Institute

Zitieren

APA

Woolman, M., Kiyota, T., Belgadi, S. A., Fujita, N., Fiorante, A., Ramaswamy, V., Daniels, C., Rutka, J. T., McIntosh, C., Munoz, D. G., Ginsberg, H. J., Aman, A., & Zarrine-Afsar, A. (2024). Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass Spectrometry. Analytical Chemistry, 96(3), 1019-1028. https://doi.org/10.1021/acs.analchem.3c03156

Vancouver

Woolman M, Kiyota T, Belgadi SA, Fujita N, Fiorante A, Ramaswamy V, et al. Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass Spectrometry. Analytical Chemistry. 2024;96(3):1019-1028. doi:10.1021/acs.analchem.3c03156

BibTeX
@article{Woolman2024,
  author = {Woolman, Michael and Kiyota, Taira and Belgadi, Siham A and Fujita, Naohide and Fiorante, Alexa and Ramaswamy, Vijay and Daniels, Craig and Rutka, James T and McIntosh, Chris and Munoz, David G and Ginsberg, Howard J and Aman, Ahmed and Zarrine-Afsar, Arash},
  title = {Lipidomic-Based Approach to 10 s Classification of Major Pediatric Brain Cancer Types with Picosecond Infrared Laser Mass Spectrometry},
  journal = {Analytical Chemistry},
  year = {2024},
  volume = {96},
  number = {3},
  pages = {1019--1028},
  doi = {10.1021/acs.analchem.3c03156}
}
Kostenlos starten →